{ "cik": 1737287, "cik_padded": "0001737287", "entityName": "Allogene Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001628280-26-017242", "filed": "2026-03-12", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 386000.0, "cash": 51688000.0, "eps_diluted": -0.87, "free_cash_flow": -149632000.0, "net_income": -190886000.0, "operating_cash_flow": -149246000.0, "operating_income": -209315000.0, "stockholders_equity": 292542000.0, "total_assets": 415905000.0, "total_liabilities": 123363000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4216932953216974, "roa_avg2y": -0.39577655333993356, "roa_period_end": -0.45896538873059955, "roe_avg2y": -0.5341552857688524, "roe_period_end": -0.65250801594301 } }, { "accn": "0001628280-26-017242", "filed": "2026-03-12", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 694000.0, "cash": 75218000.0, "eps_diluted": -1.32, "free_cash_flow": -200994000.0, "net_income": -257590000.0, "operating_cash_flow": -200300000.0, "operating_income": -273199000.0, "stockholders_equity": 422179000.0, "total_assets": 548710000.0, "total_liabilities": 126531000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2997093649849945, "roa_avg2y": -0.4323622987595118, "roa_period_end": -0.4694465200196825, "roe_avg2y": -0.55134137832134, "roe_period_end": -0.6101440384291971 } }, { "accn": "0001737287-25-000036", "filed": "2026-03-12", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1516000.0, "cash": 83155000.0, "eps_diluted": -2.09, "free_cash_flow": -239249000.0, "net_income": -327265000.0, "operating_cash_flow": -237733000.0, "operating_income": -327737000.0, "stockholders_equity": 512233000.0, "total_assets": 642837000.0, "total_liabilities": 130604000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2549699062731218, "roa_avg2y": -0.44695632934903745, "roa_period_end": -0.5090948405272254, "roe_avg2y": -0.5551027677537814, "roe_period_end": -0.6388987043005819 } }, { "accn": "0001737287-25-000036", "filed": "2025-03-13", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 5191000.0, "cash": 61904000.0, "eps_diluted": -2.38, "free_cash_flow": -225710000.0, "net_income": -340414000.0, "operating_cash_flow": -220519000.0, "operating_income": -335536000.0, "stockholders_equity": 666882000.0, "total_assets": 821579000.0, "total_liabilities": 154697000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.23197057350475797, "roa_avg2y": -0.36361111660018364, "roa_period_end": -0.41434116500056606, "roe_avg2y": -0.4276337525328469, "roe_period_end": -0.5104561226723768 } }, { "accn": "0001737287-24-000021", "filed": "2024-03-14", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 21446000.0, "cash": 173314000.0, "eps_diluted": -1.34, "free_cash_flow": -206258000.0, "net_income": -182051000.0, "operating_cash_flow": -184812000.0, "operating_income": -180192000.0, "stockholders_equity": 925200000.0, "total_assets": 1050828000.0, "total_liabilities": 125628000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.13578469520103761, "roa_avg2y": -0.15978798037616015, "roa_period_end": -0.17324528847727694, "roe_avg2y": -0.18781145916993053, "roe_period_end": -0.19676934716817984 } }, { "accn": "0001737287-24-000021", "filed": "2024-03-14", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 65958000.0, "cash": 183351000.0, "eps_diluted": -2.63, "free_cash_flow": -181051000.0, "net_income": -316381000.0, "operating_cash_flow": -115093000.0, "operating_income": -258243000.0, "stockholders_equity": 1013457000.0, "total_assets": 1227829000.0, "total_liabilities": 148212000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.14624399456513695, "roa_avg2y": -0.3252219973879939, "roa_period_end": -0.2576751322863363, "roe_avg2y": -0.38524791778286493, "roe_period_end": -0.3121799938231222 } }, { "accn": "0001737287-24-000018", "filed": "2024-03-14", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 50791000.0, "cash": 175126000.0, "eps_diluted": -1.83, "free_cash_flow": -188141000.0, "net_income": -184594000.0, "operating_cash_flow": -137350000.0, "operating_income": -202008000.0, "stockholders_equity": 629023000.0, "total_assets": 717802000.0, "total_liabilities": 88779000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.14113792341456513, "roa_avg2y": -0.2475019391187116, "roa_period_end": -0.25716562506095, "roe_avg2y": -0.2771292618829038, "roe_period_end": -0.2934614473556611 } }, { "accn": "0001737287-22-000013", "filed": "2022-02-23", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3234000.0, "cash": 92432000.0, "free_cash_flow": -47887000.0, "net_income": -211505000.0, "operating_cash_flow": -44653000.0, "operating_income": -192842000.0, "stockholders_equity": 703164000.0, "total_assets": 773855000.0, "total_liabilities": 70691000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.10053273489541557, "roa_period_end": -0.2733134760387928, "roe_avg2y": -0.6015825656107696, "roe_period_end": -0.3007904272687453 } }, { "accn": "0001737287-21-000009", "filed": "2021-02-25", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD", "total_liabilities": "USD" }, "fundamentals": { "stockholders_equity": -2000.0, "total_liabilities": 2000.0 }, "period_end": "2017-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001628280-26-017242", "filed": "2026-03-12", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001737287.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001737287.json" }, "ticker": "ALLO" }